Table 1

Patientcharacteristics in individuals with atrial fibrillation, by income

CharacteristicAll participants<$20 000$20 000–$49 000$50 000–$99 999>$100 000P value (standard)P value (trend)
n=295n=35n=99n=97n=64
Age71.3±9.969.9±11.473.2±10.271.6±9.268.8±9.40.040.06
Sex (Male)177 (60.0%)16 (45.7%)55 (55.6%)66 (68.0%)40 (62.5%)0.090.04
White race281 (95.3%)34 (97.1%)92 (92.9%)95 (97.9%)60 (93.8%)0.010.64
BMI31.4±7.4133.2±9.0931.4±7.5031.4±7.7730.5±5.390.410.13
CHF54 (18.3%)9 (25.7%)23 (23.2%)17 (17.5%)5 (7.8%)0.05<0.01
HTN210 (71.2%)29 (82.9%)69 (69.7%)71 (73.2%)41 (64.1%)0.240.16
DM65 (22.0%)7 (20.0%)22 (22.2%)22 (22.7%)14 (21.9%)0.990.84
Stroke/TIA22 (7.5%)2 (5.7%)11 (11.1%)3 (3.1%)6 (9.4%)0.160.68
Vascular disease56 (19.0%)4 (11.4%)26 (26.3%)16 (16.5%)10 (15.6%)0.130.42
Education<0.01<0.01
 ≤HS or vocational100 (33.9%)21 (60.0%)47 (47.5%)28 (28.9%)4 (6.3%)
 Some college62 (21.0%)7 (20.0%)24 (24.2%)22 (22.7%)9 (14.1%)
 Bachelor’s70 (23.7%)6 (17.1%)18 (18.2%)29 (29.9%)17 (26.6%)
 Graduate63 (21.4%)1 (2.9%)10 (10.1%)18 (18.6%)34 (53.1%)
S-TOHFLA Score29.6±4.9227.3±5.8828.9±6.2630.2±3.5131.0±2.89<0.01<0.01
Treatment
 Pulmonary vein isolation59 (20.0%)6 (17.1%)20 (20.2%)15 (15.5%)18 (28.1%)0.250.28
 Electrical cardioversion58 (19.7%)6 (17.1%)18 (18.2%)19 (19.6%)15 (23.4%)0.830.38
 Cardioversion by medication5 (1.7%)0 (0.0%)0 (0.0%)3 (3.1%)2 (3.1%)0.230.07
Anti-arrhythmics (any)72 (24.4%)6 (17.1%)21 (21.2%)25 (25.8%)20 (31.3%)0.350.07
  • Standard p value using χ2 tests for categorical variables and ANOVA for continuous variables. P value trend test using the Jonckheere-Terpstra test for ordered differences among classes.

  • BMI, body mass index; CHF, congestive heart failure; DM, diabetes mellitus; HS, high school; HTN, hypertension; S-TOFHLA, short-test of functional health literacy in adults; TIA, transient ischaemic attack.